Mirati Therapeutics announces proposed public offering of common stock
Mirati Therapeutics announced it has commenced an underwritten public offering of shares of its common stock. Mirati expects to grant the underwriters of the offering a 30-day option to purchase additional shares of its common stock at the public offering price. June 24, 2019